Health Minister Hala Zayed has agreed to look into repricing 330 meds manufactured by state-owned companies, Public Enterprises Minister Hisham Tawfik tells Al Mal. According to Tawfik, the repricing will not necessarily entail an increase in the retail price, and will assess possible scenarios to reduce manufacturing costs. He did note that some of these meds are currently being sold at less than their cost of production. This comes as private pharma companies are also pushing to raise med prices, saying the most recent increases in fuel prices and electricity tariffs, along with a global rise in the cost of raw materials made raising med prices a necessity.
More from Enterprise
Israel’s Arkia Airlines moves flights to Egypt’s Taba to bypass wartime airspace restrictions
Israel’s Arkia shifts some flights to Egypt as airspace tightens…
Miga guarantee unlocks USD 313 mn for National Bank of Egypt trade finance
Plus: Incolease taps securitization market with debut EGP 2 bn…
Private capital hasn’t frozen in MENA — but the exit playbook could change if the war drags on
PE and VC-backed companies were already pivoting to local exchanges…
Telda moves into investing with zero-fee stock trading
Telda claims users can sell a position and immediately spend…